CME and CFTC Engage in Heated Battle Over On-Chain Perpetual Futures

The Commodity Futures Trading Commission's decision to allow blockchain-based perpetual futures products has led to a rare public feud with the CME Group, the largest derivatives exchange operator in the US. The CME has filed a lawsuit against the CFTC, challenging its approval of crypto perps, which are decentralized derivative contracts that enable users to speculate on asset prices with leverage and no expiration date. The CME argues that these products are harmful to its traditional futures contracts and that the CFTC's approval did not consider the potential consequences. The dispute has significant implications for the US approach to the rapidly growing market, with non-US perps volume reportedly reaching $60 trillion in volume last year. The CFTC's move has been seen as a diversion from the law by the CME, which claims that futures contracts require an end date, whereas perps are designed for traders to take a financial position on an asset's future without any deadlines. The lawsuit has sparked a heated debate, with some voicing frustration and outrage at the CME's stance, while others see it as a typical response from a large incumbent trying to maintain its dominance. The outcome of the case is uncertain, but it is likely to have a significant impact on the future of on-chain perpetual futures in the US.